ACHC

Business Context and Reporting Period

Company: Acadia Healthcare Company, Inc. (ACHC)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Acadia is the leading publicly traded pure-play provider of behavioral healthcare services in the U.S., operating acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), and residential treatment centers. As of December 31, 2025, the company operated 277 facilities with over 12,500 beds across 40 states and Puerto Rico.

Key Financial Metrics

Revenue Mix (2025): Medicaid (57.7%), Commercial (24.6%), Medicare (14.3%), Other (3.4%).
Capital Expenditures: $571.8 million total ($104.4 million maintenance; $467.4 million expansion).

Material Changes vs. Prior Period

• Significant Net Loss: The company reported a net loss of $1.1 billion in 2025, a sharp reversal from a net income of $255.6 million in 2024. This was primarily driven by a non-cash goodwill impairment charge of $996.2 million and increased legal settlements.
• Goodwill Impairment: A triggering event in Q4 2025 (higher liability expenses, lower revenue projections, and stock price decline) led to a $996.2 million impairment charge, reducing goodwill from $2.26 billion to $1.30 billion.
• Legal Settlements: Legal settlements expense totaled $151.0 million in 2025, compared to $0 in 2024. This included $147.5 million for the 2019 Securities Litigation and $3.5 million for the Desert Hills Litigation.
• Debt Restructuring: In February 2025, the company refinanced its prior credit facility with a new $1.65 billion Credit Facility ($1.0 billion revolving, $650 million term loan). Additionally, $550 million of 7.375% Senior Notes due 2033 were issued in March 2025.
• Operating Expenses: "Other operating expenses" increased to $553.3 million (16.7% of revenue) from $440.8 million in 2024, partly due to a $52.7 million unfavorable adjustment to self-insured liability reserves.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary & Outlook: Management maintains a strategy focused on organic growth, joint ventures, and acquisitions. Despite the net loss, same-facility revenue grew 4.9% and patient days grew 2.1%. The company remains compliant with all financial covenants under its new credit facility (Consolidated Total Net Leverage Ratio of 4.0x).

Key Risks and Contingencies:

• Regulatory & Legislative: The "One Big Beautiful Bill Act" (OBBBA) passed in July 2025 reduces federal Medicaid expenditures and tightens eligibility, potentially increasing uncompensated care. Expiration of enhanced ACA premium tax credits on Dec 31, 2025, may increase uninsured patients.
• Legal Proceedings: The company faces ongoing government investigations (DOJ, SEC) regarding admissions, length of stay, and billing practices. A sixth lawsuit related to the Desert Hills Litigation was filed in 2024 with an unquantifiable liability.
• Insurance & Liability: Professional and general liability reserves increased significantly to $181.8 million due to higher claim frequency and less favorable insurance terms.
• Executive Turnover: The company experienced significant leadership changes, including the departure of the CEO in January 2026 and the CFO and COO in late 2025.

Investor Verification Checklist

• Goodwill Valuation: Verify the assumptions used in the Q4 2025 goodwill impairment test, specifically regarding future revenue projections and discount rates.
• Legal Exposure: Monitor the status of the DOJ/SEC investigations and the potential liability of the sixth Desert Hills lawsuit.
• Reimbursement Rates: Assess the financial impact of the OBBBA and the expiration of ACA subsidies on Medicaid and commercial payor mix.
• Debt Covenants: Confirm ongoing compliance with the new Credit Facility covenants, particularly the 5.0x leverage ratio, given the recent impairment and legal costs.
• Insurance Reserves: Review the adequacy of the $181.8 million liability reserve given the trend of increasing claim frequency.